T-cell Lymphoma Forum


January 24 - 26, 2013

San Francisco, CA

The 5th annual T-cell Lymphoma Forum is a 2½-day meeting focusing on the latest information on novel agents and treatment approaches. The Forum, cochaired by Francine M. Foss, MD, Owen A. O'Connor, MD, PhD, and Kensei Tobinai, MD, PhD, will be held at the Park 55 Wyndham, San Francisco, from January 24-26, 2013.

Drs Foss, O'Connor, and Tobinai have developed a very comprehensive program intended to update attendees on all the latest findings about T-cell lymphoma, including topics such as epidemiology, prognostic markers, pathobiology, and treatment strategies and advances.

The T-cell Lymphoma Forum provides just the platform for attendees and world leaders in TCL to gather and exchange ideas and information to improve outcomes for this patient population. Plan to join our distinguished international faculty for this informative program.

This meeting is intended for hematologists, oncologists, and other clinicians and scientists with an interest in T-cell lymphoma.

We look forward to that having you participate in what we anticipate will be a very stimulating program.
+ show speakers and program
Program co-chairs:

Francine M. Foss, MD
Yale Cancer Center
New Haven, CT USA

Owen A. O'Connor, MD, PhD
Columbia University Medical Center
The New York Presbyterian Hospital
New York, NY USA

Kensei Tobinai, MD, PhD
National Cancer Center Hospital
Tokyo, Japan


Ranjana H. Advani, MD
Stanford Cancer Institute
Stanford, CA USA

Shiro Akinaga, PhD
Kyowa Hakko-Kirin
Tokyo, Japan

Richard F. Ambinder, MD, PhD
Sidney Kimmel Cancer Center at Johns Hopkins
Baltimore, MD USA

Stephen M. Ansell, MD, PhD
Mayo Clinic
Rochester, MN USA

Peter D. Aplan, MD
National Cancer Institute
Bethesda, MD USA

Susan E. Bates, MD
National Cancer Center
Bethesda, MD USA

Achiléa L. Bittencourt, Md, PhD
Universitary Hospital Prof. Edgard Santos
Federal University of Bahia
Salvadore, Bahia, Brazil

Francesco A. d'Amore, MD, PhD
Åarhus University Hospital
Åarhus, Denmark

Madeleine Duvic, MD
University of Texas
MD Anderson Cancer Center
Houston, TX USA

Massimo R Federico, MD
University of Modena and Reggio Emilia
Modena, Italy

Steven M. Fruchtman, MD
Spectrum Pharmaceuticals, Inc.
Irvine, CA USA

Steven M. Horwitz, MD
Memorial Sloan-Kettering Cancer Center
New York, NY USA

Fumihiro Ishida
Shinshu University School of Medicine
Matsumoto, Nagano, Japan

Tomohiro Kinoshita, MD, PhD
Aichi Cancer Center Hospital
Nagoya, Aichi, Japan

Sumimasa Nagai, MD, PhD
Office of New Drug V,
Pharmaceuticals and Medical Devices Agency (PMDA)
Chiyoda-ku, Tokyo, Japan

Shigeo Nakamura, MD
Nagoya University Hospital
Nagoya, Japan

Pier Paolo Piccaluga, MD, PhD
Institute of Hematology and Medical Oncology "L. and A. Seràgnoli"
S. Orsola Malpighi Hospital
Bologna, Italy

Stefano A. Pileri, MD, PhD
Bologna University
Policlinico S.Orsola-Malpighi
Bologna, Italy

Miles Prince
Peter MacCallum Cancer Centre
East Melbourne, Australia

Barbara Pro, MD
Fox Chase Cancer Center
Philadelphia, PA USA

Christiane Querfeld, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY USA

Andrei R. Shustov, MD
University of Washington School of Medicine
Seattle, WA USA

Thomas A. Waldmann, MD
National Institutes of Health
National Cancer Institute
Bethesda, MD USA

Mariusz A. Wasik, MD
University of Pennsylvania Medical Center
Philadelphia, PA USA

Dennis C. Weisenburger, MD
University of Nebraska Medical Center
Omaha, NE USA

Pier Luigi Zinzani, MD, PhD
Bologna University
Institute of Hematology "Seragnoli"
Bologna, Italy

24 Jan - 26 Jan 2013
San Francisco
United States of America
meeting website